Orchestra BioMed Holdings, Inc. Quarterly Operating Margin in % from Q4 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Orchestra BioMed Holdings, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q3 2024.
  • Orchestra BioMed Holdings, Inc. Operating Margin for the quarter ending September 30, 2024 was -2.27K %, a 67.4% decline year-over-year.
  • Orchestra BioMed Holdings, Inc. annual Operating Margin for 2023 was -1.87K %, a 102% decline from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -2.27K -914 -67.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -2.8K -1.78K -174% Apr 1, 2024 Jun 30, 2024
Q1 2024 -2.45K -1.43K -141% Jan 1, 2024 Mar 31, 2024
Q4 2023 -1.87K -942 -102% Oct 1, 2023 Dec 31, 2023
Q3 2023 -1.36K Jul 1, 2023 Sep 30, 2023
Q2 2023 -1.02K Apr 1, 2023 Jun 30, 2023
Q1 2023 -1.02K Jan 1, 2023 Mar 31, 2023
Q4 2022 -924 Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.